Skip to main content
. 2018 Aug 23;11:5111–5119. doi: 10.2147/OTT.S153888

Figure 3.

Figure 3

miR-16 inhibits oral carcinoma tumor growth in vivo. BAL B/c null mice were subcutaneously injected with the oral squamous carcinoma cell with lenti-miR-16 or lenti-vector. (A) The tumor volumes of mice were measured every 5 days. (B and C) In the end of the study, the mice were sacrificed. Then, the tumors were excised from mice and weighted. Data presented as mean ± SD, n=8. *p<0.05, compared with lenti-vector group. **p<0.01.